Pharmacokinetic/Pharmacodynamic Background and Methods and Scientific Evidence Base for Dosing of Second-line Tuberculosis Drugs-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pharmacokinetic/Pharmacodynamic Background and Methods and Scientific Evidence Base for Dosing of Second-line Tuberculosis Drugs

Published:2018-11-28 Issue:suppl_3 Volume:67 Page:S267-S273
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:

Author:

Gumbo Tawanda¹^ORCID,Alffenaar Jan-Willem C²

Affiliation:

1. Center for Infectious Diseases Research and Experimental Therapeutics, Baylor Research Institute, Baylor University Medical Center, Dallas, Texas

2. University of Groningen, University Medical Center Groningen, Department of Clinical Pharmacy and Pharmacology, The Netherlands

Funder

National Institute of Allergy and Infectious Diseases

National Institutes of Health

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/article-pdf/67/suppl_3/S267/26826091/ciy608.pdf

Reference60 articles.

1. Pharmacokinetics-pharmacodynamics of antimicrobial therapy: it’s not just for mice anymore;Ambrose;Clin Infect Dis,2007

2. Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men;Craig;Clin Infect Dis,1998

3. “Continuous” vs. “discontinuous” therapy with penicillin; the effect of the interval between injections on therapeutic efficacy;Eagle;N Engl J Med,1953

4. Comparative antibiotic dose-effect relations at several dosing intervals in murine pneumonitis and thigh-infection models;Leggett;J Infect Dis,1989

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Meropenem-vaborbactam restoration of first-line drug efficacy and comparison of meropenem-vaborbactam-moxifloxacin versus BPaL MDR-TB regimen;International Journal of Antimicrobial Agents;2023-12

2. Analysis of Mycobacterium tuberculosis Complex Strains Isolated from the Samples of Patients Living in Northern Syria;Mikrobiyoloji Bulteni;2023-07-14

3. Omadacycline pharmacokinetics/pharmacodynamics in the hollow fiber model and clinical validation of efficacy to treat pulmonary Mycobacterium abscessus disease;International Journal of Antimicrobial Agents;2023-07

4. Advances in the design of combination therapies for the treatment of tuberculosis;Expert Opinion on Drug Discovery;2022-12-28

5. Pharmacokinetics and pharmacodynamics of anti-tuberculosis drugs: An evaluation of in vitro, in vivo methodologies and human studies;Frontiers in Pharmacology;2022-12-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3